Aurélia Tison1,2,3, Luis Sagaon-Teyssier4,5, Caroline Sansonetti6, Jean-François Blatier6, Alain Paraponaris5,7. 1. Aix Marseille University, INSERM, IRD, SESSTIM, 23 rue Stanislas Torrents, 13006, Marseille, France. aurelia.tison@hotmail.fr. 2. Observatoire Régional de la Santé PACA, 23 rue Stanislas Torrents, 13006, Marseille, France. aurelia.tison@hotmail.fr. 3. Aix Marseille School of Economics, Centre de la Vieille Charité, 2 rue de la Charité, 13002, Marseille, France. aurelia.tison@hotmail.fr. 4. Aix Marseille University, INSERM, IRD, SESSTIM, 23 rue Stanislas Torrents, 13006, Marseille, France. 5. Observatoire Régional de la Santé PACA, 23 rue Stanislas Torrents, 13006, Marseille, France. 6. Caisse Nationale du RSI, Saint-Denis, 264 avenue du Président Wilson, 93457, La Plaine Saint Denis, France. 7. Aix Marseille University, CNRS, EHESS, Cent Marseille, GREQAM, Centre de la Vieille-Charité, 2 rue de la Charité, 13236, Marseille Cedex 02, France.
Abstract
PURPOSE: The aim of this study was to investigate whether the labor market mobility of a population of cancer survivors 2 years after diagnosis differed compared to the French general population by focusing on the differences between self-employed workers and salaried staff. METHODS: Coarsened exact matching was implemented to reduce the sampling bias introduced by the comparison of individuals from two different surveys. Then, labor market mobility was analyzed by estimating transition probability matrices from 2010 to 2012 under the framework of a continuous-time Markov technique and by estimating a two-step model. RESULTS: Salaried employees and self-employed workers from the general population were more likely to remain employed 2 years after 2010 compared to salaried employees and self-employed workers who survived cancer. There was no major difference between salaried and self-employed workers surviving cancer in terms of job retention. CONCLUSIONS: French workers surviving cancer face the same difficulties that were observed in the National Cancer Survey of 2004: unemployment and inactivity caused by the diagnosis of cancer. Among cancer survivors, self-employed workers do not seem to be particularly more affected by inactivity than salaried staff. However, unemployment insurance is not compulsory for them, contrary to salaried staff. In this regard, self-employed workers might be a more vulnerable group.
PURPOSE: The aim of this study was to investigate whether the labor market mobility of a population of cancer survivors 2 years after diagnosis differed compared to the French general population by focusing on the differences between self-employed workers and salaried staff. METHODS: Coarsened exact matching was implemented to reduce the sampling bias introduced by the comparison of individuals from two different surveys. Then, labor market mobility was analyzed by estimating transition probability matrices from 2010 to 2012 under the framework of a continuous-time Markov technique and by estimating a two-step model. RESULTS: Salaried employees and self-employed workers from the general population were more likely to remain employed 2 years after 2010 compared to salaried employees and self-employed workers who survived cancer. There was no major difference between salaried and self-employed workers surviving cancer in terms of job retention. CONCLUSIONS: French workers surviving cancer face the same difficulties that were observed in the National Cancer Survey of 2004: unemployment and inactivity caused by the diagnosis of cancer. Among cancer survivors, self-employed workers do not seem to be particularly more affected by inactivity than salaried staff. However, unemployment insurance is not compulsory for them, contrary to salaried staff. In this regard, self-employed workers might be a more vulnerable group.
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: Sara Paltrinieri; Stefania Fugazzaro; Lucia Bertozzi; Maria Chiara Bassi; Martina Pellegrini; Massimo Vicentini; Elisa Mazzini; Stefania Costi Journal: Support Care Cancer Date: 2018-05-29 Impact factor: 3.603